Renewable Acetone - BioBiz

Acetone (C₃H₆O) is a widely used industrial solvent and chemical intermediate, essential in producing acrylic plastics, synthetic fibers, pharmaceuticals, and cosmetics. Traditionally derived as a by-product of petroleum-based cumene oxidation, acetone production is tied to fossil fuels and co-produces phenol.

The move toward renewable acetone involves fermentation and biochemical conversion of sugar-based feedstocks and biomass residues, reducing emissions and decoupling production from oil volatility.

How Renewable Acetone is Produced

Pathways:

  • ABE Fermentation (Acetone-Butanol-Ethanol)
    • Clostridium acetobutylicum ferments sugars into acetone, butanol, and ethanol (ratio ~3:6:1)
    • Feedstocks: molasses, corn, wheat, cassava, lignocellulosic hydrolysates
    • Acetone separated post-distillation from the ABE mixture
  • Synthetic Biology Route
    • Engineered microbes (e.g., E. coli, Clostridium beijerinckii) optimized to produce acetone as a dominant product, reducing butanol/ethanol co-formation
    • Use of CRISPR and pathway rewiring to improve carbon flux to acetoacetate → acetone
  • Thermochemical Conversion
    • Pyrolysis of lignin or glycerol with catalytic cracking can yield acetone among other volatile organics
    • Still under early development

Case Study: Green Biologics & Cobalt Technologies

Highlights:

  • Green Biologics revived the ABE fermentation process using improved Clostridium strains
  • Cobalt Technologies focused on woody biomass fermentation for acetone-butanol production

Timeline:

  • 2012: Green Biologics acquired UK-based ButylFuel™ technology
  • 2014: Demo plant established in Minnesota, USA
  • 2016: Commercial production started at 21,000-ton facility
  • 2018: Shifted focus to specialty chemicals; acetone positioned as green solvent for pharma/cosmetics
  • 2020: Green Biologics assets acquired post-market exit due to cost pressures

Global Startups and Innovators

  • Solugen (USA) – Working on enzymatic oxidation pathways for solvents, including renewable acetone derivatives
  • BioC3 (USA) – Developing non-pathogenic microbial hosts for high-yield acetone production
  • CysBio (Denmark) – Synthetic biology firm engineering microbes for specialty chemical synthesis, including acetone analogs
  • Antec (Italy) – Exploring glycerol-to-acetone route using heterogeneous catalysis

India’s Position

  • India consumes ~120,000 tons/year of acetone, primarily imported or produced as phenol co-product
  • Sugarcane molasses and starch-based industries (e.g., Godavari Biorefineries) offer feedstock potential. National Centre for Microbial Resource (NCMR) maintains several solventogenic clostridia strains

Commercialization Outlook

Market and Demand:

  • Global acetone market size: ~$6.2 billion (2024), expected to reach $8.5 billion by 2030
  • Applications:
    • Solvents in cosmetics, paints, and coatings
    • Intermediate for MMA (methyl methacrylate), BPA
    • Pharma-grade solvent

Key Drivers:

  • Growing demand for green solvents in cosmetics and pharmaceuticals
  • Need for low-carbon intermediates in plastics and coatings
  • Sustainability commitments by FMCG majors (L’Oréal, Unilever, etc.) adopting bio-based solvents

Challenges to Address

1. Co-product Separation

  • ABE fermentation produces multiple solvents, requiring energy-intensive separation, especially at commercial scale.

2. Microbial Tolerance

  • High acetone concentrations inhibit microbial growth, limiting titers; strains must be engineered for robustness.

3. Feedstock Cost & Consistency

  • Lignocellulosic and molasses-based processes must ensure low-cost, year-round availability of fermentable sugars.

4. Market Competition

  • Petro-acetone is low-cost (~$0.60–0.80/kg); renewable acetone still above $1.5/kg, requiring market premium or policy support.

5. Regulatory Alignment

  • Regulatory approval for bio-acetone in pharma and cosmetics can be a bottleneck due to purity and traceability standards.

Progress Indicators

  • 2012–2014: Green Biologics demonstrated pilot-scale ABE process with high selectivity
  • 2016: Commercial production initiated at renewable solvents plant (21 KTPA)
  • 2018–2020: R&D into strain improvement for acetone-first fermentation via CRISPR
  • 2021–2023: Solugen and BioC3 launched synthetic biology platforms for selective acetone production
  • 2024: India’s Godavari Biorefineries explores downstream bio-solvent diversification from ethanol and sugarcane residues

TRL: 6–7
Renewable acetone from ABE fermentation is at demonstration to early commercial scale; newer synthetic biology routes are in advanced lab/pilot stages.

Conclusion

Renewable acetone represents a viable path to decarbonize the solvent and plastics intermediate sector, with fermentation-based methods being the most mature. While companies like Green Biologics have laid the groundwork, cost-effective scale-up and co-product integration remain key to market success. Emerging synthetic biology platforms are addressing selectivity and titers, indicating a strong pipeline for bio-acetone 2.0.

India’s acetone-heavy industries and molasses-rich feedstock base offer an attractive ecosystem for future commercialization. With rising sustainability mandates across consumer goods and pharma, bio-based acetone is poised to secure a niche in the global green chemicals portfolio.


Wish to have bio-innovations industry or market research support from specialists for climate & environment? Talk to BioBiz team – Call Muthu at +91-9952910083 or send a note to ask@biobiz.in

Expert Consulting Assistance for Indian Bioenergy & Biomaterials

Talk to BioBiz

Call Muthu – 9952910083

Email – ask@biobiz.in